InsidersTradesSigma
Discover the detailed record of transactions filed by Vickers Philip J., Director. Officer active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 5 disclosures have been recorded. Total volume traded: €68k. The latest transaction was filed on 4 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Philip J. Vickers is a Board Member at Revance Therapeutics, Inc. and AVROBIO, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Revance Therapeutics is a biopharmaceutical company, while AVROBIO focuses on gene therapy. Mr. Vickers's experience in these sectors is valuable for guiding strategic decisions.